BLFS – BioLife Solutions, Inc.
BLFS — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.66
Margin Of Safety %
-13
Put/Call OI Ratio
0.12
EPS Next Q Diff
-0.01
EPS Last/This Y
0.23
EPS This/Next Y
0.15
Price
18.61
Target Price
32.4
Analyst Recom
1
Performance Q
-26.84
Upside
-158.4%
Beta
1.98
Ticker: BLFS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | BLFS | 24.22 | 0.05 | 0.00 | 154 |
| 2026-03-02 | BLFS | 22.5 | 0.05 | 32.00 | 172 |
| 2026-03-03 | BLFS | 20.16 | 2.00 | 2.00 | 492 |
| 2026-03-04 | BLFS | 20.66 | 2.00 | 2.00 | 492 |
| 2026-03-05 | BLFS | 20.11 | 2.00 | 999.99 | 495 |
| 2026-03-06 | BLFS | 19.88 | 2.03 | 0.00 | 500 |
| 2026-03-09 | BLFS | 19.87 | 2.03 | 0.00 | 500 |
| 2026-03-10 | BLFS | 18.65 | 2.01 | 0.00 | 502 |
| 2026-03-11 | BLFS | 19.01 | 1.98 | 1.00 | 504 |
| 2026-03-12 | BLFS | 18.16 | 1.98 | 0.00 | 506 |
| 2026-03-13 | BLFS | 18.15 | 1.98 | 0.00 | 506 |
| 2026-03-17 | BLFS | 19.4 | 1.98 | 0.00 | 506 |
| 2026-03-18 | BLFS | 19.13 | 1.34 | 0.00 | 410 |
| 2026-03-19 | BLFS | 19.54 | 1.34 | 0.00 | 410 |
| 2026-03-20 | BLFS | 18.88 | 1.34 | 0.00 | 410 |
| 2026-03-23 | BLFS | 19.16 | 1.34 | 0.00 | 410 |
| 2026-03-24 | BLFS | 19.68 | 1.34 | 0.00 | 410 |
| 2026-03-25 | BLFS | 19.86 | 1.34 | 0.00 | 410 |
| 2026-03-26 | BLFS | 19.66 | 0.09 | 999.99 | 161 |
| 2026-03-27 | BLFS | 18.59 | 0.12 | 3.33 | 166 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | BLFS | 24.23 | 131.3 | - | 0.08 |
| 2026-03-02 | BLFS | 22.49 | 131.3 | - | 0.08 |
| 2026-03-03 | BLFS | 20.17 | 131.3 | - | 0.15 |
| 2026-03-04 | BLFS | 20.64 | 131.3 | - | 0.14 |
| 2026-03-05 | BLFS | 20.10 | 131.3 | - | 0.14 |
| 2026-03-06 | BLFS | 19.88 | 131.3 | - | 0.14 |
| 2026-03-09 | BLFS | 19.90 | -57.7 | - | 0.14 |
| 2026-03-10 | BLFS | 18.66 | -57.7 | - | 0.14 |
| 2026-03-11 | BLFS | 18.99 | -57.7 | - | 0.14 |
| 2026-03-12 | BLFS | 18.15 | -57.7 | - | 0.14 |
| 2026-03-13 | BLFS | 18.35 | -57.7 | - | 0.14 |
| 2026-03-17 | BLFS | 19.40 | -57.7 | - | 0.14 |
| 2026-03-18 | BLFS | 19.11 | -57.7 | - | 0.14 |
| 2026-03-19 | BLFS | 19.53 | -57.7 | - | 0.14 |
| 2026-03-20 | BLFS | 18.88 | -57.7 | - | 0.14 |
| 2026-03-23 | BLFS | 19.16 | -57.7 | - | 0.14 |
| 2026-03-24 | BLFS | 19.70 | -57.7 | - | 0.14 |
| 2026-03-25 | BLFS | 19.86 | -57.7 | - | 0.14 |
| 2026-03-26 | BLFS | 19.69 | -57.7 | - | 0.14 |
| 2026-03-27 | BLFS | 18.61 | -57.7 | - | 0.14 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | BLFS | -35.78 | -6.75 | 6.92 |
| 2026-03-02 | BLFS | -35.42 | 4.00 | 6.90 |
| 2026-03-03 | BLFS | -35.42 | 4.00 | 6.90 |
| 2026-03-04 | BLFS | -35.42 | 4.00 | 6.90 |
| 2026-03-05 | BLFS | -35.47 | 4.00 | 6.90 |
| 2026-03-06 | BLFS | -35.47 | 4.00 | 6.90 |
| 2026-03-09 | BLFS | -37.74 | 4.00 | 6.90 |
| 2026-03-10 | BLFS | -37.74 | 4.00 | 6.90 |
| 2026-03-11 | BLFS | -37.74 | 4.00 | 6.43 |
| 2026-03-12 | BLFS | -37.74 | 4.00 | 6.43 |
| 2026-03-13 | BLFS | -37.74 | 4.00 | 6.43 |
| 2026-03-17 | BLFS | -37.67 | 4.05 | 6.43 |
| 2026-03-18 | BLFS | -37.66 | 4.05 | 6.43 |
| 2026-03-19 | BLFS | -37.66 | 4.05 | 6.43 |
| 2026-03-20 | BLFS | -37.66 | 4.05 | 6.43 |
| 2026-03-23 | BLFS | -37.66 | 3.35 | 6.43 |
| 2026-03-24 | BLFS | -37.66 | 3.35 | 6.43 |
| 2026-03-25 | BLFS | -37.66 | 3.35 | 6.66 |
| 2026-03-26 | BLFS | -37.66 | 3.35 | 6.66 |
| 2026-03-27 | BLFS | -37.66 | 3.35 | 6.66 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.04
Avg. EPS Est. Current Quarter
0.01
Avg. EPS Est. Next Quarter
0.03
Insider Transactions
-37.66
Institutional Transactions
3.35
Beta
1.98
Average Sales Estimate Current Quarter
25
Average Sales Estimate Next Quarter
27
Fair Value
16.19
Quality Score
48
Growth Score
54
Sentiment Score
85
Actual DrawDown %
69.3
Max Drawdown 5-Year %
-85.1
Target Price
32.4
P/E
Forward P/E
54.45
PEG
P/S
9.33
P/B
2.41
P/Free Cash Flow
84.39
EPS
-0.31
Average EPS Est. Cur. Y
0.14
EPS Next Y. (Est.)
0.29
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-15.51
Relative Volume
0.96
Return on Equity vs Sector %
-28.6
Return on Equity vs Industry %
-10.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
◆
BLFS
Healthcare
$18.59
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
38.2
Range 1M
12.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
159.1%
EPS NY
131%
52W%
6.6%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-11.7% upside
Upside
-11.7%
Quality
48
MoS
-13%
BioLife Solutions, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 155
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
BLFS
Latest News
—
Caricamento notizie per BLFS…
stock quote shares BLFS – BioLife Solutions, Inc. Stock Price stock today
news today BLFS – BioLife Solutions, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BLFS – BioLife Solutions, Inc. yahoo finance google finance
stock history BLFS – BioLife Solutions, Inc. invest stock market
stock prices BLFS premarket after hours
ticker BLFS fair value insiders trading